Scarica l'app Stockscreener
2.90
4.69%
0.13
Precedente Chiudi:
$2.77
Aprire:
$2.8
Volume 24 ore:
106.15K
Relative Volume:
0.84
Capitalizzazione di mercato:
$83.54M
Reddito:
$40,000
Utile/perdita netta:
$-38.64M
Rapporto P/E:
-1.5749
EPS:
-1.8414
Flusso di cassa netto:
$-22.21M
1 W Prestazione:
+9.02%
1M Prestazione:
-12.91%
6M Prestazione:
-43.47%
1 anno Prestazione:
-69.38%
Intervallo 1D:
$2.7501
$2.96
Intervallo di 1 settimana:
$2.66
$2.96
Portata 52W:
$2.501
$12.00
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
Nome
Neonc Technologies Holdings Inc
Settore
Industria
Telefono
310 663 7831
Indirizzo
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
2.90 | 83.54M | 40,000 | -38.64M | -22.21M | -1.8414 |
VRTX
Vertex Pharmaceuticals Inc
|
524.52 | 132.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
245.81 | 98.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
805.67 | 82.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
890.05 | 55.97B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
386.46 | 43.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Neonc Technologies Holdings Inc Stock (NTHI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-24 | Iniziato | Roth Capital | Buy |
| 2026-05-19 | Iniziato | Alliance Global Partners | Buy |
| 2026-05-18 | Iniziato | Maxim Group | Buy |
| 2026-04-24 | Iniziato | BTIG Research | Buy |
Neonc Technologies Holdings Inc Borsa (NTHI) Ultime notizie
NeOnc Technologies Holdings, Inc. (NTHI) stock price, news, quote and history - Yahoo Finance UK
NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi - GlobeNewswire Inc.
Two Abu Dhabi children are receiving an investigational brain cancer treatment; a third is expected to join this week. - Stock Titan
NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors - GlobeNewswire Inc.
NeOnc Technologies Announces FDA Meeting on November 17, 2026, for NEO212 Progress - Kalkine Media
Neonc Technologies CFO Garnett sells $16,809 stock By Investing.com - Investing.com Nigeria
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Canada
Form 4 Neonc Technologies Holdings Inc For: 27 September - Investing.com India
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Nigeria
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Australia
Neonc Technologies CFO Garnett sells $16,809 stock - Investing.com
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com UK
Neonc Technologies CFO Garnett sells $16,809 stock By Investing.com - Investing.com UK
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier - GlobeNewswire Inc.
[8-K] NEONC TECHNOLOGIES HOLDINGS, INC. Reports Material Event - Stock Titan
NeOnc Charting New Nasal Route to Treating Brain Cancer - GlobeNewswire Inc.
Neonc Technologies CFO sells $16,809 in company stock - Investing.com
NeOnc Technologies (NTHI) CFO sells shares under preset plan - Stock Titan
NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution - Yahoo Finance
A $6 million payment kept NeOnc from issuing new shares - Stock Titan
NeOnc leaders (NTHI) keep buying after positive Phase 2a data - Stock Titan
NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results - TradingView
Neonc technologies CEO Thomas Chen buys $39,999 in stock - Investing.com
Neonc technologies CEO Amir Heshmatpour acquires $174,795 in stock - Investing.com
NeOnc Technologies (NTHI) CEO is buying more of his own stock - Stock Titan
NeOnc Technologies (NTHI) CFO adds shares in open-market buy - Stock Titan
NeOnc (NTHI) CEO adds shares in IRA trades - Stock Titan
NeOnc Technologies (NTHI) insider may sell $18,900 in stock - Stock Titan
48.9% had no cancer progression at six months in NeOnc’s 24-person study - Stock Titan
Neonc Technologies CEO Amir Heshmatpour buys $135,619 in shares - Investing.com
NeOnc (NTHI) CEO now holds 3.13M shares after stock buy - Stock Titan
Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer - marketscreener.com
NeOnc Technologies Announces $15 Million Registered Direct Offering - The Globe and Mail
NeOnc Technologies Announces $15 Million Registered Direct Offering - The Globe and Mail
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com Nigeria
NeOnc raises USD 15m to advance Phase II CNS cancer programs after NEO100 efficacy readout - AllSci
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com India
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com Canada
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com UK
NeOnc Technologies Launches $15 Million Registered Direct Offering at $4.20 With Warrants - TradingView
NeOnc Technologies Company Profile & Introduction - Moomoo
NeOnc Technologies Holdings Secures $15 Million Registered Direct Offering After Positive Phase 2a Data and Insider Buying - Quiver Quantitative
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data - marketscreener.com
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors - Stocktwits
NeOnc Technologies prices $15M registered direct offering - investing.com
NeOnc Technologies prices $15M registered direct offering By Investing.com - Investing.com Canada
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 - GlobeNewswire
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors - Yahoo Finance
Cancer-drug developer NeOnc plans a stock sale of about $15 million - Stock Titan
In a brain-cancer trial, 48.9% had no worsening at six months. NeOnc also redeemed $6M in stock. - Stock Titan
Neonc Technologies Holdings Inc Azioni (NTHI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Neonc Technologies Holdings Inc Azioni (NTHI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| KEITHLY GARNETT | Officer |
Sep 15 '26 |
Proposed Sale |
3.78 |
5,000 |
18,900 |
0 |
| Heshmatpour Amir F | CEO, President |
Sep 14 '26 |
Buy |
3.96 |
15,000 |
59,400 |
3,148,000 |
| CHEN THOMAS C | CEO |
Sep 14 '26 |
Buy |
3.81 |
5,242 |
19,998 |
24,503 |
| GARNETT KEITHLY | CFO |
Sep 14 '26 |
Buy |
3.89 |
257 |
1,001 |
242,357 |
| CHEN THOMAS C | CEO |
Sep 11 '26 |
Buy |
3.60 |
5,556 |
20,002 |
19,261 |
| Heshmatpour Amir F | CEO, President |
Sep 11 '26 |
Buy |
3.67 |
37,000 |
135,620 |
3,133,000 |
| CHEN THOMAS C | CEO |
Aug 18 '26 |
Buy |
5.49 |
12,757 |
69,998 |
13,705 |
| Heshmatpour Amir F | CEO, President |
Aug 18 '26 |
Buy |
5.54 |
9,000 |
49,860 |
3,096,000 |
| CHEN THOMAS C | CEO |
Aug 17 '26 |
Buy |
4.04 |
2,472 |
9,998 |
583,531 |
| Heshmatpour Amir F | CEO, President |
Aug 17 '26 |
Buy |
4.37 |
3,000 |
13,120 |
3,087,000 |
4.38%
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):